Watchlist Price Alert

Gracell Biotechnologies I... (GRCL)

NASDAQ: GRCL · Real-Time Price · USD

10.25

0.01 (0.05%)

At close: Feb 21, 2024, 9:00 PM

Gracell Biotechnologies Cash Flow Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-4.16B	-451.75M	-211.9M	-138.66M	-60.79M
Depreciation & Amortization	531.08M	60.27M	21.59M	5.12M	2.99M
Stock-Based Compensation	165.15M	60.38M	n/a	n/a	n/a
Other Working Capital	n/a	n/a	n/a	n/a	n/a
Other Non-Cash Items	55.97M	1.3M	2.91M	-2.56M	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	103.34M	25.26M	-10.75M	703K	-4.05M
Operating Cash Flow	-3.31B	-304.55M	-198.15M	-135.39M	-61.86M
Capital Expenditures	-331.55M	-56.74M	-79.4M	-56.43M	-11.36M
Cash Acquisitions	1.79B	10M	28.05M	-97.8K	n/a
Purchase of Investments	-1.79B	-10M	-28.05M	-80.2M	-335M
Sales Maturities Of Investments	1.79B	25.13M	13.51M	178M	233M
Other Investing Acitivies	-1.79B	-10M	-28.05M	97.8K	n/a
Investing Cash Flow	-331.17M	-41.62M	-93.94M	41.37M	-113.36M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	-44.7M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	228.34M	1.46B	756.47M	394.8M	138.69M
Financial Cash Flow	228.34M	1.46B	756.47M	394.8M	138.69M
Net Cash Flow	-2.57B	1.07B	442.25M	300.17M	-36.52M
Free Cash Flow	-3.64B	-361.29M	-277.55M	-191.82M	-73.21M